Metropolis Healthcare has acquired Core Diagnostics, a Delhi-NCR-based diagnostic company, for ₹246.83 crore.
The deal includes 55% cash and 45% equity swap, making it a strategic mix of financial investment and equity expansion. This acquisition aims to boost Metropolis’ diagnostic capabilities and widen its market reach, especially in specialized tests. Core Diagnostics is known for high-end diagnostic services, and this move is expected to strengthen Metropolis’ position in India’s growing diagnostic sector. It reflects the company’s push to dominate advanced healthcare services in India.